Context Therapeutics Competitors and Similar CompaniesClear all

Context Therapeutics's competitors and similar companies include Sunesis Pharmaceuticals, HUYA Bioscience International, IDEAYA Biosciences and Celltrion Healthcare.
Context Therapeutics
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating medicines treating hormone-responsive cancers.
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
HUYA Bioscience International
HUYA Bioscience International
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
IDEAYA Biosciences
IDEAYA Biosciences
IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.
Celltrion Healthcare
Celltrion Healthcare
Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
Founding Date
Founding Date
2015
Founding Date
1987
Founding Date
2004
Founding Date
2015
Founding Date
2002
Type
Type
Public
Type
Subsidiary
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Philadelphia, US HQ
Philadelphia, US
Locations
South San Francisco, US HQ
Locations
San Diego, US HQ
Chengdu Shi, CN
Guangzhou Shi, CN
Hangzhou, CN
Shenzhen Shi, CN
Shenzhen Shi, CN
Suzhou Shi, CN
see more
Locations
South San Francisco, US HQ
San Diego, US
Locations
Incheon, KR HQ
Employees
Employees
2
Employees
42
Employees
1113% increase
Employees
56
Employees
6301% increase
Valuation ($)
Valuation ($)
168 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2.5 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$218.7m (FY, 2025)
Revenue (est.)
₩2t (FY, 2022)
Net income
Net income
($36.1m) (FY, 2025)
Net income
($114.8m) (FY, 2021)
Net income
N/A
Net income
($113.7m) (FY, 2025)
Net income
₩147.2b (FY, 2022)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 171.7m
Total funding raised
$ 12.6m
Total funding raised
$ 140m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Sunesis Pharmaceuticals
HQ
South San Francisco, US

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

View company
HUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase

HUYA Bioscience International is a company specializing in the biopharmaceutical products.

View company
IDEAYA Biosciences
HQ
South San Francisco, US
Employees
56

IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.

View company
Celltrion Healthcare
HQ
Incheon, KR
Employees
630↑ 1% increase

Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,

View company